top of page

ASGCT 2026: SonoThera has a unique ultrasound-mediated nonviral approach to gene therapy. It has plans to be in the clinic for DMD next year

  • May 14
  • 1 min read

Co-Founder & CEO Ken Greenberg describes the idea around and advantages of this approach, including no limitation on cargo size. He describes how it would work for DMD, and what other conditions and uses they are thinking of next.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page